ACARBOSE Drug Patent Profile
✉ Email this page to a colleague
When do Acarbose patents expire, and what generic alternatives are available?
Acarbose is a drug marketed by Avet Lifesciences, Dash Pharms, Hangzhou Zhongmei, Hikma, Impax Labs, Strides Pharma, Virtus Pharm, and Watson Labs. and is included in eight NDAs.
The generic ingredient in ACARBOSE is acarbose. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the acarbose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acarbose
A generic version of ACARBOSE was approved as acarbose by HIKMA on May 7th, 2008.
Summary for ACARBOSE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Clinical Trials: | 92 |
| Patent Applications: | 4,483 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ACARBOSE |
| What excipients (inactive ingredients) are in ACARBOSE? | ACARBOSE excipients list |
| DailyMed Link: | ACARBOSE at DailyMed |
Recent Clinical Trials for ACARBOSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Zambia | Phase 3 |
| University Teaching Hospital, Lusaka, Zambia | Phase 3 |
| University of Alabama at Birmingham | Phase 2 |
Pharmacology for ACARBOSE
| Drug Class | alpha-Glucosidase Inhibitor |
| Mechanism of Action | alpha Glucosidase Inhibitors |
Medical Subject Heading (MeSH) Categories for ACARBOSE
Anatomical Therapeutic Chemical (ATC) Classes for ACARBOSE
US Patents and Regulatory Information for ACARBOSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | ACARBOSE | acarbose | TABLET;ORAL | 202271-001 | Feb 7, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Strides Pharma | ACARBOSE | acarbose | TABLET;ORAL | 090912-003 | Jul 27, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Watson Labs | ACARBOSE | acarbose | TABLET;ORAL | 077532-003 | May 7, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hangzhou Zhongmei | ACARBOSE | acarbose | TABLET;ORAL | 213821-001 | Aug 18, 2020 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Dash Pharms | ACARBOSE | acarbose | TABLET;ORAL | 091053-001 | Jan 6, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hikma | ACARBOSE | acarbose | TABLET;ORAL | 078470-003 | May 7, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
